Compounded vs FDA-Approved Medications: What's the Difference?

It's late, you've got two tabs open, and one word keeps tripping you up: compounded. Here's the plain answer on compounded vs FDA-approved medications: an FDA-approved drug was reviewed by the FDA for safety, effectiveness and quality before it was sold, and a compounded drug wasn't.^[1]

That doesn't make compounded medicines automatically bad. It also doesn't make them interchangeable with the approved version. This guide walks through what each term means, how compounding pharmacies are overseen, where the real risks sit, and a short checklist to run before you start anything.

The short version

• FDA approval means the FDA reviewed a drug's safety, effectiveness and quality before sale. Compounded drugs don't get that review.^[1]
• A compounded drug is not a generic. Generics are FDA-approved and shown to be equivalent to a brand-name drug, and compounded drugs are not approved at all.^[1]
• The FDA says compounding may be appropriate when a patient's medical need can't be met by an approved drug. A licensed clinician makes that call for you.^[3]
• Before you start, ask who makes it, what exactly is in it, and how to measure your dose.^[3][7]

What does "FDA-approved" actually mean?

It means the FDA looked at the evidence and decided a drug's benefits outweigh its known and potential risks for the people it's meant for.^[5] Think of it as a driving test before you get a license.

The company that wants to sell the drug has to test it first. Then it sends the FDA the evidence to show the drug is safe and that it works for its intended use.^[5]

That review is what most of us lean on without thinking about it. The FDA says consumers and clinicians rely on the approval process to verify safety, effectiveness and quality.^[1]

So "FDA-approved" is a claim about one specific product. Compounded medicines sit in a different category, and that's where it gets interesting.

Compounded vs FDA-approved medications: what's actually different?

The biggest difference is the review. Under section 503A, compounding means a licensed pharmacist (or sometimes a physician) prepares a medicine for an individual patient from a valid prescription.^[4]

An off-the-rack jacket has been worn by thousands of people. A tailored one is made for you, but nobody tested that exact jacket on a crowd first. Compounding works a bit like that: it can be built around one person, yet it skips the large-scale testing and review that approved drugs go through.

The FDA states it directly: compounded drugs are not FDA-approved, so the agency does not verify their safety, effectiveness or quality before they're marketed.^[1] Here's how the two compare side by side.

Question	FDA-approved drug	Compounded drug (503A pharmacy)
Reviewed by the FDA before it's sold?	Yes, for safety, effectiveness and quality[1]	No[1]
Who prepares it?	A drug company with an approved application[5]	A licensed pharmacist in a state-licensed pharmacy, or a licensed physician[4]
Prescription needed?	Yes, for prescription drugs	Made from a valid prescription for an identified patient[4]
Federal manufacturing standards (CGMP)?	Yes, like other conventionally manufactured drugs[4]	Not required under section 503A, though other federal law still applies[1]
Label directions for use?	Required[4]	Exempt from that requirement, so labels may lack key information[2][4]

Notice that none of this says compounded drugs are always poor quality. It says nobody at the FDA checked first. Which brings up a question people ask all the time.

Is a compounded medication the same as a generic?

No. A generic is approved by the FDA and has to establish therapeutic equivalence to a brand-name drug, while a compounded drug is not approved by the FDA.^[1]

A generic application also has to show the drug is the same type of product as the brand and that the manufacturer can make it correctly.^[6] Compounded drugs don't go through that path.

That's why the FDA lists "it's the same as the FDA-approved drug" as a red flag when a telehealth company says it.^[3] A compounded medicine isn't a copy with a different price tag. It's a separate thing, made by a different process.

It also changes how you read the research. The big weight-loss trials you've seen headlines about, like STEP 1 for semaglutide and SURMOUNT-1 for tirzepatide, studied FDA-approved branded products.^[10][11] Compounded versions weren't part of them, and even with approved products, individual results vary. If you'd like the background on how these medicines work, start with our plain-English guide to GLP-1 medications.

Who checks a compounding pharmacy, and what rules apply?

Mostly your state. Day to day, state boards of pharmacy have primary responsibility for overseeing state-licensed pharmacies that aren't registered with the FDA as outsourcing facilities.^[1]

You'll see two numbers in this world. Section 503A covers compounding by a licensed pharmacist in a state-licensed pharmacy, or by a licensed physician. Section 503B covers outsourcing facilities.^[4]

Here's the part most people miss. Outsourcing facilities must follow current good manufacturing practice, the FDA's manufacturing standards. Drugs compounded by a pharmacist under 503A don't have to.^[1] Other federal rules, such as those on insanitary conditions, apply either way.^[1]

503A also has a patient-specific rule: the drug must be made from a valid prescription for an identified patient.^[4] And one condition says the pharmacist can't regularly compound large amounts of drugs that are essentially copies of commercially available products.^[4]

That's why "why compounded, for me?" is a fair question to put to your prescriber. Let's look at when the answer is a good one.

When might a clinician consider a compounded medication?

When an approved drug can't meet a patient's medical need. The FDA says a compounded drug might be appropriate in that case, or when the approved drug isn't commercially available.^[3]

The classic examples are practical ones. Someone who's allergic to a dye in a tablet may need it made without that dye. Someone who can't swallow a pill may need a liquid.^[1]

Those are decisions for a licensed clinician who knows your health history. It's not something you can decide from a website, and it isn't something a marketing page can decide for you. Think of it as "who a clinician may consider," not a box you tick.

The FDA's own framing is worth keeping in mind. Compounded drugs should only be used in patients whose medical needs can't be met by an FDA-approved drug.^[1] If a clinician offers one, ask what need it meets in your case.

What are the risks of compounded medications?

The main risk is uncertainty about quality and dosing. The FDA says poor compounding practices can cause contamination or a drug with too much or too little active ingredient, which can lead to serious injury or death.^[1] That's about poor practices, not every compounded product, but with no FDA review, you can't assume.

Compounded labels may also lack important information, such as adequate directions for safe use.^[2]

For compounded semaglutide and tirzepatide, the FDA has been specific. It received multiple reports of adverse events, some needing hospitalization, that may be linked to dosing errors.^[3] Patients measured the wrong dose, and sometimes clinicians miscalculated it.^[3]

Why does that happen? Vials come with syringes, and instructions may switch between milliliters, milligrams and "units." The FDA says that confusion, plus little experience drawing medicine from a vial, may have contributed.^[7] If you want to see how units and doses relate, our semaglutide weight loss dosage chart explains the syringe side of it.

One more ingredient-level warning. The FDA is aware that some semaglutide sold by compounders may be a salt form, such as semaglutide sodium or acetate. These are different active ingredients from the ones in approved drugs, and the FDA isn't aware of any lawful basis for using them in compounding.^[3]

The FDA has also received reports tied to doses beyond what the approved label describes, whether more in one dose, more often, or stepping up faster.^[3] More isn't a plan.

What does trouble look like? The FDA's dosing-error reports included stomach effects, fainting, headache, dehydration, acute pancreatitis and gallstones.^[7]

Compounded versions weren't studied, so the labels of the approved drugs are the best guide to what to watch for. Here's what they say:

• Boxed warning. Both the semaglutide and tirzepatide labels warn that these drugs caused thyroid C-cell tumors in rodents. Whether that happens in people hasn't been determined.^[8][9]
• Who shouldn't take them. Anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or a past serious allergic reaction to the drug.^[8][9]
• Common side effects. In the approved-drug trials, nausea was the most common one: 44% on semaglutide vs 16% on placebo, and 25% to 29% on tirzepatide vs 8%. Diarrhea, vomiting and constipation were also common. These were different trials, so don't compare the numbers, and your experience may differ.^[8][9]
• Other warnings. Pancreatitis, gallbladder problems, dehydration that can harm your kidneys, and allergic reactions. Tell every provider you take one before surgery or sedation.^[8][9]
• Interactions. Insulin and sulfonylureas raise the risk of low blood sugar. With tirzepatide, birth control pills may work less well, so the label advises a non-oral or added barrier method for 4 weeks after starting and after each dose increase.^[8][9]
• Pregnancy. Both labels say these drugs may harm a fetus and to stop when pregnancy is recognized. The semaglutide label says to stop at least 2 months before a planned pregnancy. Tell your clinician if you're pregnant, planning to be, or breastfeeding.^[8][9]

Get emergency care for severe or lasting belly pain (sometimes spreading to your back), repeated vomiting or diarrhea with dehydration, fainting, swelling of your face, lips or tongue, or trouble breathing or swallowing. Call your clinician about a neck lump or hoarseness that doesn't go away. If you think you took too much, call Poison Help at 1-800-222-1222 or go to the ER.^[8][9] For more on each medicine, see our semaglutide injections guide and tirzepatide injections guide.

How can you protect yourself if you're prescribed a compounded medicine?

Run a quick five-minute checklist. It takes less time than your coffee order and covers most of what the FDA flags.

• Confirm a licensed clinician reviewed you. The FDA lists skipping screening and a prescription from a licensed doctor as a warning sign.^[3]
• Know the pharmacy. Online buyers may not know who compounded their drug.^[1] The FDA says to fill prescriptions at a state-licensed pharmacy, and to watch for spelling errors or odd addresses on the label.^[3]
• Ask how to measure your dose. Have your clinician or pharmacy show you the right syringe and which unit the instructions use.^[7]
• Ask what's in the vial. Which form of the active ingredient is it, and which pharmacy made it?^[3]
• Handle vials the FDA way. Discard a multi-dose vial 28 days after first use, even if some is left. Use a new sterile needle and syringe every dose. Don't use an injectable that arrives warm.^[3]
• Be wary of "same as the brand" and too-good-to-be-true discounts. The FDA names both as red flags.^[3]
• Make sure you can reach a clinician after delivery. That's another FDA red flag if it's missing.^[3]

If something goes wrong, tell your clinician first. You can also report it to the FDA: MedWatch takes reports from patients as well as clinicians.^[3]

Curious how a telehealth company stacks up against a list like this? Our guide on how to verify ShopMedRx before you choose shows what to check.

Getting compounded medications through ShopMedRx

ShopMedRx offers clinician-prescribed compounded medications online, with no membership fee. Pricing is shown up front on each product page, such as weight management. We don't bill insurance, and products are HSA/FSA reimbursable.

1. You complete a short online health assessment.
2. A licensed clinician in your state reviews it and prescribes only if it's clinically appropriate. A prescription isn't guaranteed, and if you aren't prescribed medication, you aren't charged for it.
3. A state-licensed 503A compounding pharmacy prepares your medication and ships it in unmarked packaging.

Compounded medications are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality.^[2] Whether a compounded product is appropriate for you is your clinician's decision.

GLP-1 plans include free 1-on-1 care coaching, and you can cancel any time. ShopMedRx is available in all 50 states plus DC, though some services may not be available everywhere. See how ShopMedRx works, or check if you qualify online.

Bottom line

Compounded and FDA-approved medications aren't the same thing, and the difference starts with one fact: the FDA reviews approved drugs before they're sold and doesn't review compounded ones. If a compounded medicine is on the table, ask your clinician why, ask who makes it, and make sure you understand how to measure your dose.

Frequently asked questions

Are compounded medications FDA-approved?

No. The FDA states that compounded drugs are not FDA-approved, which means it does not verify their safety, effectiveness or quality before they are marketed.^[1] That's different from the FDA-approved products, which went through the agency's review process before sale.^[5]

Is a compounded drug the same as a generic drug?

No. A generic drug is approved by the FDA and must show therapeutic equivalence to a brand-name drug, among other requirements.^[1] A compounded drug is not approved by the FDA, so it can't be described as a generic or as equivalent to an approved product.

Are compounded medications less safe than FDA-approved ones?

The honest answer is that they carry more uncertainty. The FDA doesn't review them before they're marketed, and poor compounding practices can cause contamination or incorrect strength.^[1] Quality depends on the pharmacy and on how the medicine is used, so ask who prepared yours.

Do compounded medications require a prescription?

Under section 503A, a compounded drug must be made based on a valid prescription for an identified individual patient.^[4] The FDA also lists skipping screening and a licensed doctor's prescription as a red flag with telehealth sellers.^[3]

Were compounded semaglutide and tirzepatide studied in clinical trials?

No. The major trials studied FDA-approved branded products, and compounded versions weren't part of them, so trial averages can't be assumed to apply.^[10][11] Individual results may vary even with approved drugs. The FDA says it does not review compounded GLP-1 drugs for safety, effectiveness or quality.^[3]

How do I report a problem with a compounded medication?

Tell your prescribing clinician first, especially if symptoms are severe. You can also file a report with the FDA's MedWatch program, which the FDA encourages patients as well as clinicians to use.^[3] Keep the label and packaging handy, since the pharmacy and product details help.

Talk to a licensed clinician

Before you start, stop or change any treatment, talk to a licensed clinician about your health history and other medicines. If you would like to see whether treatment from ShopMedRx could be appropriate for you, you can check if you qualify.

Important information

• This article is for general education and is not medical advice. Talk to a licensed clinician before starting, stopping or changing any treatment.
• All medications available through ShopMedRx are prescription only and are prescribed only if appropriate after a licensed clinician's review.
• Most medications we offer are compounded. Compounded medications are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. They are not the same as, or generic versions of, brand-name drugs.
• Individual results may vary. Nothing in this article promises a specific result.
• Prescriptions are written by clinicians licensed in the patient's state, only when clinically appropriate. All prescriptions are filled by state-licensed 503A compounding pharmacies.

Sources

1. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2025. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
2. U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. 2026. https://www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs
3. U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2026-10. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
4. U.S. Food and Drug Administration. FD&C Act Provisions that Apply to Human Drug Compounding. 2021. https://www.fda.gov/drugs/human-drug-compounding/fdc-act-provisions-apply-human-drug-compounding
5. U.S. Food and Drug Administration. Development & Approval Process | Drugs. 2022. https://www.fda.gov/drugs/development-approval-process-drugs
6. U.S. Food and Drug Administration. What Is the Approval Process for Generic Drugs?. 2026. https://www.fda.gov/drugs/generic-drugs/what-approval-process-generic-drugs
7. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. 2024. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
8. Novo Nordisk (DailyMed). WEGOVY (semaglutide) injection and tablets: Prescribing Information and Medication Guide. 2026-06. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
9. Eli Lilly and Company (DailyMed). ZEPBOUND (tirzepatide) injection: Prescribing Information and Medication Guide. 2026-09. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
10. New England Journal of Medicine. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
11. New England Journal of Medicine. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038